Answers are grounded in this paper and cite their sources.
Reactive oxygen species (ROS), at physiological concentrations, play a key role in regulating follicular growth, angiogenesis, and the biosynthesis of sex steroids in ovarian tissue. An imbalance between ROS and the body’s antioxidant system leads to oxidative stress (OS), which results in the degradation of both the quantitative and qualitative characteristics of oocytes. This review analyzes the relationship between OS and premature ovarian insufficiency (POI), highlights potential pathogenic mechanisms, and explores treatment approaches for POI through the modulation of OS levels via antioxidant therapy. It has been established that OS plays a significant role in genetic material damage, disrupts signaling pathways, transcription factor expression, and alters the oocyte microenvironment, ultimately leading to apoptosis of granulosa cells (GCs), disruption of meiotic division, reduction in mitochondrial DNA (mtDNA) content, and other pathophysiological changes that accelerate ovarian aging. Antioxidants, mesenchymal stem cells (MSCs), biological enzymes, and other antioxidant agents have the potential to slow down the progression of POI by reducing ROS concentrations, representing a promising direction for improving the quality of life and reproductive outcomes in patients with POI.
No takes yet. Share an insight, caveat, or question.
Adamyan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: